These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27416070)

  • 1. Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations.
    Zonta E; Garlan F; Pécuchet N; Perez-Toralla K; Caen O; Milbury C; Didelot A; Fabre E; Blons H; Laurent-Puig P; Taly V
    PLoS One; 2016; 11(7):e0159094. PubMed ID: 27416070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
    Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
    Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing.
    Milbury CA; Correll M; Quackenbush J; Rubio R; Makrigiorgos GM
    Clin Chem; 2012 Mar; 58(3):580-9. PubMed ID: 22194627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
    Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
    JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    Riva A; BØrgesen M; Guldmann-Christensen M; Hauge Kyneb M; Voogd K; Andersen C; Epistolio S; Merlo E; Yding Wolff T; Hamilton-Dutoit S; Lorenzen J; Christensen UB; Frattini M
    PLoS One; 2017; 12(6):e0178027. PubMed ID: 28636636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.
    Watanabe M; Kawaguchi T; Isa SI; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kawashima O; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Watanabe K; Matsumura A; Koh Y
    EBioMedicine; 2017 Jul; 21():86-93. PubMed ID: 28625519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach.
    Pender A; Garcia-Murillas I; Rana S; Cutts RJ; Kelly G; Fenwick K; Kozarewa I; Gonzalez de Castro D; Bhosle J; O'Brien M; Turner NC; Popat S; Downward J
    PLoS One; 2015; 10(9):e0139074. PubMed ID: 26413866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR.
    Jackson JB; Choi DS; Luketich JD; Pennathur A; Ståhlberg A; Godfrey TE
    J Mol Diagn; 2016 Mar; 18(2):235-43. PubMed ID: 26752305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.
    Hu W; Yang Y; Zhang L; Yin J; Huang J; Huang L; Gu H; Jiang G; Fang J
    Cancer Med; 2017 May; 6(5):962-974. PubMed ID: 28382702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays.
    Wang J; Ramakrishnan R; Tang Z; Fan W; Kluge A; Dowlati A; Jones RC; Ma PC
    Clin Chem; 2010 Apr; 56(4):623-32. PubMed ID: 20207772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal.
    Hong HH; Hoenerhoff MJ; Ton TV; Herbert RA; Kissling GE; Hooth MJ; Behl M; Witt KL; Smith-Roe SL; Sills RC; Pandiri AR
    Toxicol Pathol; 2015 Aug; 43(6):872-82. PubMed ID: 26059825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA.
    Hussung S; Follo M; Klar RFU; Michalczyk S; Fritsch K; Nollmann F; Hipp J; Duyster J; Scherer F; von Bubnoff N; Boerries M; Wittel U; Fritsch RM
    J Mol Diagn; 2020 Jul; 22(7):943-956. PubMed ID: 32376474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
    Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
    Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.
    Zhu G; Ye X; Dong Z; Lu YC; Sun Y; Liu Y; McCormack R; Gu Y; Liu X
    J Mol Diagn; 2015 May; 17(3):265-72. PubMed ID: 25769900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment.
    Castellanos-Rizaldos E; Liu P; Milbury CA; Guha M; Brisci A; Cremonesi L; Ferrari M; Mamon H; Makrigiorgos GM
    Clin Chem; 2012 Jul; 58(7):1130-8. PubMed ID: 22587896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
    Choi H; Kratz J; Pham P; Lee S; Ray R; Kwon YW; Mao JH; Kang HC; Jablons D; Kim IJ
    Int J Oncol; 2012 Jun; 40(6):1900-6. PubMed ID: 22407457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
    Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
    J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
    Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
    Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
    Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
    Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.